共查询到20条相似文献,搜索用时 31 毫秒
1.
目的:探讨不同类型冠心病患者血清同型半胱氨酸(Hcy)、总胆红素(TBIL)、高敏C反应蛋白(hs-CRP)、尿酸的水平及临床意义。方法:选取首都医科大学附属北京地坛医院2015年9月-2018年7月收治的冠心病患者132例为冠心病组,根据临床诊断分为稳定型心绞痛52例(SAP组)、不稳定型心绞痛42例(UAP组)、急性心肌梗死38例(AMI组),另选取50例同时期于我院体检的健康志愿者为对照组,检测各组Hcy、TBIL、hs-CRP、尿酸的水平,采用Pearson相关分析Hcy、TBIL、hs-CRP、尿酸水平之间的相关性,采用Logistic回归分析冠心病的影响因素。结果:冠心病组患者的血清Hcy、hs-CRP、尿酸水平显著高于对照组,TBIL水平显著低于对照组(P0.05)。AMI、UAP组患者的血清Hcy、hs-CRP、尿酸水平显著高于SAP组,TBIL水平显著低于SAP组(P0.05),且AMI组患者的血清Hcy、hs-CRP、尿酸水平显著高于UAP组,TBIL水平显著低于UAP组(P0.05)。经Pearson相关分析显示,Hcy与hs-CRP、尿酸呈正相关,与TBIL呈负相关,hs-CRP与尿酸呈正相关(P0.05),TBIL与hs-CRP、尿酸无明显相关性(P0.05)。经Logistic回归分析显示,Hcy、hs-CRP、尿酸、高血压、糖尿病均是冠心病的独立危险因素(P0.05),TBIL是冠心病的保护因素(P0.05)。结论:冠心病患者血清Hcy、hs-CRP、尿酸水平升高,TBIL水平降低,Hcy、TBIL、hs-CRP、尿酸与患者的病情相关,也是冠心病的影响因素。 相似文献
2.
BackgroundHyperuricemia may be associated with an increased risk of coronary heart disease (CHD) mortality; however, the results from prospective studies are conflicting. The objective of this study was to assess the association between hyperuricemia and risk of CHD mortality by performing a meta-analysis. MethodsPubmed and Embase were searched for relevant prospective cohort studies published until July 2015. Studies were included only if they reported data on CHD mortality related to hyperuricemia in a general population. The pooled adjusted relative risk (RR) was calculated using a random-effects model. ResultsA total of 14 studies involving 341 389 adults were identified. Hyperuricemia was associated with an increased risk of CHD mortality (RR: 1.14; 95 % CI: 1.06–1.23) and all-cause mortality (RR: 1.20; 95 % CI: 1.13–1.28). For each increase of 1 mg/dl of serum uric acid (SUA), the overall risks of CHD and all-cause mortality increased by 20 and 9 %, respectively. According to the gender subgroup analyses, hyperuricemia increased the risk of CHD mortality in women (RR: 1.47; 95 % CI: 1.21–1.73) compared to men (RR: 1.10; 95 % CI: 1.00–1.19). The risk of all-cause mortality was greater in women. ConclusionsHyperuricemia may modestly increase the risk of CHD and all-cause mortality. Future research is needed to determine whether urate–lowering therapy has beneficial effects for reducing CHD mortality. 相似文献
3.
BackgroundMultiple studies investigated the associations between serum uric acid and coronary heart disease (CHD) risk. However, further investigations still remain to be carried out to determine whether there exists a causal relationship between them. We aim to explore the associations between genetic variants in uric acid related loci of SLC2A9 and ABCG2 and CHD risk in a Chinese population. ResultsA case–control study including 1,146 CHD cases and 1,146 controls was conducted. Association analysis between two uric acid related variants (SNP rs11722228 in SLC2A9 and rs4148152 in ABCG2) and CHD risk was performed by logistic regression model. Adjusted odds ratios (ORs) with 95% confidence intervals (CIs) were calculated. Compared with subjects with A allele of rs4148152, those with G allele had a decreased CHD risk and the association remained significant in a multivariate model. However, it altered to null when BMI was added into the model. No significant association was observed between rs11722228 and CHD risk. The distribution of CHD risk factors was not significantly different among different genotypes of both SNPs. Among subjects who did not consume alcohol, the G allele of rs4148152 showed a moderate protective effect. However, no significant interactions were observed between SNP by CHD risk factors on CHD risk. ConclusionsThere might be no association between the two uric acid related SNPs with CHD risk. Further studies were warranted to validate these results. Electronic supplementary materialThe online version of this article (doi:10.1186/s12863-015-0162-7) contains supplementary material, which is available to authorized users. 相似文献
4.
目的:探讨脑小血管病(Cerebral small vessel disease,CSVD)患者血清尿酸(Uric acid,UA)水平和步态障碍之间的相关性。方法:将我院自2018年1月至2019年1月收治的CSVD患者172例作为研究对象,根据患者血清尿酸水平分为研究组87例,对照组85例。收集和比较两组的临床资料,使用Logistic回归分析血清尿酸和CSVD患者脑室旁、深部白质高信号、步态障碍之间的相关性。结果:两组的年龄、性别、体质指数、血糖指标、血脂指标水平,合并高血压、糖尿病病史和吸烟情况比较差异无统计学意义(P0.05)。研究组血清尿酸水平、饮酒患者比例明显高于对照组(P0.05),脑室旁高信号和深部白质高信号中重度比例均明显高于对照组(P0.05);将步态障碍、脑室旁高信号与深部白质高信号作为影响因素带入相关分析,结果显示血清尿酸水平与步态障碍、脑室旁高信号与深部白质高信号比较存在正相关(P0.05)。结论:CSVD患者血清高尿酸水平与脑室旁、深部白质高信号病变程度呈明显的正相关性,也是患者步态障碍的影响因素。 相似文献
5.
目的:探讨血尿酸(SUA)水平与冠状动脉病变程度的关系。方法:将268例疑似冠心病(CHD)患者,经冠状动脉造影分为冠心病组198例和非冠心病组70例;冠心病组又分为单支病变组80例,双支病变组56例,三支病变组62例。分别检测各组研究对象血尿酸含量,同时记录年龄、性别、吸烟、高血压、糖尿病、血尿酸及冠状动脉造影结果,分析血尿酸与已知冠心病主要危险因素、冠状动脉病变程度的相关性。结果:冠心病组血尿酸水平(395.35±84.40)μmol/L,显著高于非冠心病组(282.20±66.68)μmol/L(P<0.05)。单支病变组(338.48±77.36)μmol/L、双支病变组(399.62±84.36)μmol/L、三支病变组(445.16±92.20)μmol/L,血尿酸水平呈递增趋势,各组之间的差异有统计学意义。结论:血尿酸水平可反映冠状动脉病变严重程度。降尿酸治疗有望成为心血管疾病防治的一种新途径。 相似文献
6.
BackgroundThe relationship between hyperuricemia and chronic kidney disease (CKD) has been found in various observational studies. Although hypouricemia is associated with cardiovascular events, it has not been established as a risk factor for CKD. We investigated the relationship between serum uric acid level and the loss of kidney function and incident CKD in healthy people. ResultsThe following data was obtained: mean±SD age, male, 39.6±10.4 years, female 38.4±10.8 years; eGFR, male, 81.9±16.4 ml/min/1.73m2, female, 82.1±17.5 ml/min/1.73m2; serum uric acid level, male, 5.8±1.2 mg/dl, female, 4.1±0.9 mg/dl. Both low and high serum uric acid levels were associated with the outcome and eGFR decline in males (multivariate logistic additional additive models, linear p = 0.0001, spline p = 0.043; generalized additive models, linear p = 0.0001, spline p = 0.012). In subjects with low serum uric acid levels (male, <5 mg/dl; female, <3.6 mg/dl), multivariate linear mixed models showed that low serum uric acid levels were associated with eGFR decline in a time-dependent manner (male, p = 0.0001; female, p = 0.045). ConclusionThis study showed that low as well as high levels of uric acid are associated with the loss of kidney function. Hypouricemia is a candidate predictor of kidney function decline in healthy people. 相似文献
7.
目的:观察妊娠期高血压孕产妇尿酸与Nod样受体蛋白3(nucleotide-binding oligomerization domain-leucine-rich repeats containing pyrin domain 3,NLRP3)炎症小体表达,分析二者与疾病的相关性,为妊娠期高血压的诊断提供参考。方法:选择我院产科2016年3月至2019年3月常规产检并诊断为妊娠期高血压孕产妇200例为研究组,参照《妊娠期高血压诊治指南(2015)》中各妊娠期高血压分级标准将研究组200例孕产妇分为妊娠期高血压组(86例)、轻度子痫前期组(57例)、重度子痫前期组(57例),另选择同期在我院接受常规产检的200例健康孕产妇作为对照组。检测并比较4组孕产妇血清尿酸、NLRP3炎症小体m RNA及NLRP3蛋白表达,经双变量Spearman相关性分析检验各指标与疾病的相关性。结果:4组孕产妇年龄、孕周、孕次、产次等一般资料比较差异无统计学意义(P>0.05);重度子痫前期组血清尿酸水平、NLRP3 mRNA及NLRP3蛋白表达最高,后由高至低依次为轻度子痫前期组、妊娠期高血压组、对照组,组间两两比较差异均有统计学意义(P<0.05);经双变量Spearman相关性分析检验证实,血清尿酸、NLRP3 mRNA表达和蛋白表达与妊娠期高血压发生发展均呈正相关(r=0.709、0.833、0.693,P均<0.001)。结论:妊娠期高血压孕产妇血清尿酸与NLRP3炎症小体水平上调,且随着孕产妇病情的加重升高,可考虑将其作为妊娠期高血压疾病早期诊断及预后评估的血清学参考指标。 相似文献
8.
BackgroundA high intake of fructose increases the risk for hyperuricemia. It has been reported that long-term fructose consumption suppressed renal uric acid excretion and increased serum uric acid level. However, the effect of single administration of fructose on excretion of uric acid has not been clarified. MethodsWe used male Wistar rats, which were orally administered fructose (5 g/kg). Those rats were used in each experiment at 12 h after administration. ResultsSingle administration of fructose suppressed the function of ileal uric acid excretion and had no effect on the function of renal uric acid excretion. Breast cancer resistance protein (BCRP) predominantly contributes to intestinal excretion of uric acid as an active homodimer. Single administration of fructose decreased BCRP homodimer level in the ileum. Moreover, diphenyleneiodonium (DPI), an inhibitor of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Nox), recovered the suppression of the function of ileal uric acid excretion and the Bcrp homodimer level in the ileum of rats that received single administration of fructose. ConclusionsSingle administration of fructose decreases in BCRP homodimer level, resulting in the suppression the function of ileal uric acid excretion. The suppression of the function of ileal uric acid excretion by single administration of fructose is caused by the activation of Nox. The results of our study provide a new insight into the mechanism of fructose-induced hyperuricemia. 相似文献
9.
目的:探讨阿托伐他汀对老年冠心病合并糖尿病患者的治疗效果及对血脂、尿酸水平的影响。方法:收集我院就诊的116例冠心病合并糖尿病患者,随机分为对照组和实验组,每组各58例。两组患者入院后均给予控制血糖、降血压等对症治疗。对照组患者给予阿司匹林肠溶片0.3~0.6g/次,3次/d,口服,氯吡格雷片2片/次,1次/d,口服,硝酸甘油0.25~0.5 g/次,3次/d,含服;实验组患者在对照组基础上给予阿托伐他汀片10~20 mg/次,1次/d,治疗连续4周,治疗期间根据患者情况及时调整药量。观察并比较两组患者治疗前后血清低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、甘油三酯(TG)、总胆固醇(TC)、尿酸(UA)、糖化血红蛋白(HbA1c)水平以及临床疗效。结果:与治疗前相比,两组患者治疗后的血清LDL-C、TG、TC、UA、Hb A1c水平均下降,HDL-C水平升高,差异具有统计学意义(P0.05);与对照组相比,实验组患者的LDL-C、TG、TC、UA、Hb A1c水平较低,HDL-C水平及临床治疗有效率均较高,差异均具有统计学意义(P0.05)。结论:阿托伐他汀能够有效降低老年冠心病合并糖尿病患者血糖、血脂以及尿酸水平,且临床治疗效果较好。 相似文献
10.
目的:探讨血清IgE水平与冠心病的相关性。方法:将我院收治的135例患者根据冠脉造影结果分为冠心病组(CHD)和非冠心病组(non-CHD),冠心病组根据临床症状分为稳定型心绞痛组(SAP)、不稳定型心绞痛组(UAP)和急性心肌梗死组(AMI),动脉堵塞程度用Gensini评分量化,采用SIMENS BNII全自动免疫散射比浊仪测定总IgE水平。比较CHD和non-CHD组患者及SAP、UAP和AMI组患者血清IgE水平的差异,并进一步分析血清IgE等级与冠心病Gensini积分的相关性。结果:non-CHD患者血清IgE水平(32.3(13.5,61)KU/L)明显低于CHD患者(69(26.4,169)KU/L)(P=0.001),UAP和AMI患者血清IgE水平(78.6(37.0,191.0)KU/L、118.5(75.3,148.1)KU/L)均显著高于SAP组(36.7(20.7,96.7)KU/L)(P=0.034和P=0.001),且多支血病变组患者血清IgE水平(67.2(30.9,249.0)KU/L)显著高于单支血管病变患者(34.6(18.1,59.0)KU/L)(P=0.039)。IgE水平根据四分位间距分为四个等级,随着IgE分级水平增加冠心病Gensini积分增加。结论:冠心病患者血清IgE水平升高,且与冠心病类型和血管堵塞程度都存在显著相关性,可能辅助冠心病的诊断及病情监测。 相似文献
11.
目的:探讨血清超敏C反应蛋白(hs-CRP)水平与慢性肾脏病(CKD)患者心血管并发症发生风险关系。方法:选择82例CKD患者与21例健康体检者为研究对象,根据肾小球滤过率(e GFR)将CKD患者分成CKDl~2期组、CKD3~4期组和CKD5期组。检测和比较各组hs-CRP、B型钠尿肽前体(pro-BNP)、尿素氮(BUN)、尿酸(UA)、肌酐(Cr)、前白蛋白(PA)、白蛋白(Alb)、同型半胱氨酸(Hcy)、甘油三酯(TG)、总胆固醇(TC)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)、钙(Ca)、磷(P)、血红蛋白(Hb)的水平,同时评估患者是否有心肌缺血及心室肥厚、心脏瓣膜钙化表现。结果:随着e GFR下降,CKD患者血清hs-CRP水平呈上升趋势,不同CKD分期患者血清hs-CRP水平之间差异具有统计学意义(P0.01),CKD患者血清hs-CRP水平与BUN、Cr、UA、P、TG、Hcy、pro-BNP水平之间均存在明显的正相关(P0.05);血清hs-CRP水平与白蛋白、Hb、Ca、HDL之间均存在明显的负相关(P0.05);血清hs-CRP水平与前白蛋白、胆固醇、LDL之间无显著相关性(P0.05)。以hs-CRP为因变量,其他相关指标为自变量进行多元逐步回归分析,结果显示尿酸、Hb、Hcy进入多元逐步回归方程。以心肌缺血是否阳性和瓣膜钙化是否阳性为因变量,hs-CRP为自变量做logistic回归分析,结果显示血清hs-CRP水平为心肌缺血和瓣膜钙化的危险因素(OR1)。结论:CKD患者血清hs-CRP水平升高与其肾功能降低密切相关,且为其发生心肌缺血、心脏瓣膜钙化的危险因素。 相似文献
12.
AbstractIt is well accepted that frequent and heavy intake of purine-rich foods causes elevation of serum uric acid levels, which is a risk factor of hyperuricemia. Reducing intestinal absorption of dietary purines may attenuate the elevation of serum uric acid levels and exacerbation of hyperuricemia. This reduction may be achieved by the ingestion of lactic acid bacteria that take up purines in the intestine. In this study, we investigated the degree of uptake and utilization of purines of three lactobacilli strains. Among them, Lactobacillus gasseri PA-3 (PA-3) showed the greatest incorporation of 14C-adenine. PA-3 also incorporated 14C-adenosine and 14C-AMP. Additionally, using defined growth medium, PA-3 demonstrated greater proliferation in the presence of these purines than in their absence. Although further investigation is required, ingestion of PA-3 may lower serum uric acid levels by reducing intestinal absorption of purines in humans. 相似文献
13.
To date, few studies have examined uric acid in saliva or dental calculus. The purpose of this study is to examine the uric acid concentration in saliva and serum. Saliva and blood samples were collected from 244 participants. We divided them into four groups: untreated or treated group in normal or abnormal serum uric acid concentration groups. Within the untreated group, Pearson??s correlation coefficient was used to examine the correlation between salivary and serum uric acid concentrations. We compared uric acid concentrations between saliva and serum, or between untreated and treated groups using the paired or unpaired student??s t-test. In the untreated group, uric acid concentrations in saliva and serum were significantly and positively correlated ( r?=?0.503, P?<?0.01). Within the untreated group, those with abnormal serum uric acid concentrations had significantly higher uric acid concentrations in serum and saliva compared to those with normal serum uric acid concentrations ( P?<?0.01). Within the untreated group, uric acid concentrations in serum were significantly higher than that in saliva ( P?<?0.01). Uric acid concentrations in saliva of the treated group were significantly higher than that of the untreated group ( P?<?0.01). Within the treated group, uric acid concentrations in saliva were significantly higher than that of serum, particularly in users of benzbromarone ( P?<?0.01). Uric acid concentrations in saliva were lower than that in serum among non-users of benzbromarone. In contrast, uric acid concentrations in saliva of patients taking benzbromarone were higher than that in serum. We surmise that URAT1 may influence uric acid excretion in the salivary gland. 相似文献
14.
ObjectiveTo investigate the relationship between hyperuricemia and metabolic syndrome in a population of healthy subjects. MethodsWe studied 1,573 healthy adults (25 to 64 years old) in the population laboratory of the Tehran University of Medical Sciences. The study was designed according to the World Health Organization MONICA (Multinational Monitoring of Trends and Determinants in Cardiovascular Disease) project with use of the National Cholesterol Education Program Adult Treatment Panel III criteria for metabolic syndrome. ResultsThe crude prevalence of the metabolic syndrome was 29.9% (age-adjusted, 27.5%). The rate of metabolic syndrome significantly increased in higher quartiles of serum uric acid in both sexes but especially in women ( P < .0001 versus P = .026). The bivariate correlation was significant between uric acid levels and age, total serum cholesterol, high-density lipoprotein cholesterol, triglycerides, body mass index, waist and hip circumferences, waist-to-hip ratio, and systolic and diastolic blood pressures; however, there was not a significant correlation between serum uric acid concentrations and fasting plasma glucose. ConclusionThese data indicate that an independent relationship exists between hyperuricemia and the metabolic syndrome. Moreover, hyperuricemia is significantly correlated with hypertriglyceridemia, hypertension, and visceral obesity. Early detection of hyperuricemia seems to be essential for prevention of the metabolic syndrome. (Endocr Pract. 2008;14:298-304) 相似文献
15.
【背景】高尿酸症由血液中尿酸含量明显升高而导致,利用乳酸菌对人体的益生作用缓解高尿酸血症越来越受到关注。【目的】获得具有降解尿酸能力的乳酸菌复合菌系与纯培养菌株。【方法】以泡菜为样品来源,以尿酸为底物,采用MRS培养基筛选降解尿酸的乳酸菌复合菌系,通过高效液相色谱法测定复合菌系对尿酸的降解能力。【结果】得到一组乳酸菌复合菌系,当培养温度为37 °C、pH值为6.20、静置培养72 h后复合菌系对尿酸的降解率为12.08%;通过优化培养条件,当该菌系在以牛肉膏为单一氮源、初始pH值为5.00、温度为35 °C的条件下培养72 h,尿酸降解率上升至17.19%,降解率比优化前提高了42.3%;从该菌系中分离出两株具有尿酸降解能力的菌株UA-1与UA-2,它们的尿酸降解率分别为10.85%和8.65%;通过形态学观察和16S rRNA基因序列分析,经鉴定两株菌均为布氏乳杆菌( Lactobacillus buchneri)。将两株单菌组合降解尿酸试验发现,UA-1与UA-2比例为2:1的尿酸降解率为20.2%,比原复合菌系的降解能力提高了67.22%。【结论】研究证明了乳酸菌复合菌系对尿酸的降解能力优于单个菌株,为后续利用乳酸菌复合菌系应用提供了数据支持。 相似文献
16.
摘要 目的:探讨冠心病患者动态心电图参数与血清甲壳质酶蛋白40(YKL-40)、潜在转化生长因子结合蛋白2(LTBP-2)水平的关系。 方法:选取本院2020年3月至2023年4月154例冠心病患者纳入冠心病组(其中单支病变38例,双支病变57例,多支病变59例;Gensini积分评估冠状动脉狭窄程度包括轻度42例,中度60例,重度52例),另选择于本院进行健康体检者90例纳入对照组,所有纳入对象均接受动态心电图检查,并检测血清YKL-40、LTBP-2水平,分析冠心病患者动态心电图参数与血清指标的关系。 结果:冠心病组24 h内全部正常心动周期的标准差(SDNN)、每5 min正常R-R间期标准差(SDANN)、相邻正常心动周期差值均方根(RMSSD)、相邻2个正常心动周期差值>50 ms个数百分比(PNN50)水平低于对照组,低频与高频功率之比(LF/HF)水平高于对照组(P<0.05);不同冠脉病变狭窄范围患者SDNN、SDANN、RMSSD、PNN50水平比较,多支病变<双支病变<单支病变,LF/HF水平比较,多支病变>双支病变>单支病变(P<0.05);不同冠脉病变狭窄程度患者SDNN、SDANN、RMSSD、PNN50水平比较,重度<中度<轻度,LF/HF水平比较,重度>中度>轻度(P<0.05);冠心病组血清YKL-40、LTBP-2水平高于对照组,且多支病变>双支病变>单支病变(P<0.05);不同冠脉病变狭窄程度患者血清YKL-40、LTBP-2水平比较,重度>中度>轻度(P<0.05);冠心病患者动态心电图参数SDNN、SDANN、RMSSD、PNN50水平与血清YKL-40、LTBP-2水平呈现负相关,LF/HF水平与血清YKL-40、LTBP-2水平呈现正相关(P<0.05)。 结论:冠心病患者血清YKL-40、LTBP-2呈高表达,且其表达水平随冠脉病变狭窄范围和严重程度增加而升高,与动态心电图指标SDNN、SDANN、RMSSD、PNN50水平呈现负相关,与LF/HF水平呈现正相关。 相似文献
17.
AbstractPhytic acid, a constituent of various plants, has been related to health benefits. Phytic acid has been shown to inhibit purine nucleotide metabolism in vitro and suppress elevation of plasma uric acid levels after purine administration in animal models. This study investigated the effect of phytic acid on postprandial serum uric acid (SUA) in humans. This randomized, double-blind, crossover design study included 48 healthy subjects with normal fasting SUA. Subjects consumed a control drink and a phytic acid drink with purine-rich food, and serum and urine uric acid levels were measured for 360?min after purine loading. Phytic acid lowered the incremental area under the curve (0–360?min) and incremental maximum concentration of SUA after purine loading ( p?<?0.05); tended to lower cumulative urinary uric acid excretion (0–360?min) after purine loading ( p?<?0.10); and suppressed postprandial SUA in this clinical study. Altogether, our findings suggest that phytic acid may play a beneficial role in controlling postprandial SUA. 相似文献
18.
BackgroundSo far it is unclear whether the association between serum uric acid (SUA), inflammatory cytokines and risk of atherosclerosis is causal or an epiphenomenon. The aim of the project is to investigate the independent prognostic relationship of inflammatory markers and SUA levels with adverse cardiovascular outcomes in a patient population with stable coronary heart disease (CHD). MethodsSUA, C-reactive protein (CRP) and interleukin (IL)-6 were measured at baseline in a cohort of 1,056 patients aged 30–70 years with CHD. Cox proportional hazards model was used to determine the prognostic value of these markers on a combined CVD endpoint during eight year follow-up after adjustment for covariates. ResultsFor 1,056 patients with stable coronary heart disease aged 30–70 years (mean age 58.9 years, SD 8.0) follow-up information and serum measurements were complete and n = 151 patients (incidence 21.1 per 1000 patients years) experienced a fatal or non-fatal CVD event during follow-up (p-value = 0.05 for quartiles of SUA, p = 0.002 for quartiles of CRP, p = 0.13 for quartiles of IL-6 in Kaplan-Meier analysis). After adjustment for age, gender and hospital site the hazard ratio (HR) for SUA increased from 1.37 to 1.65 and 2.27 in the second, third, and top quartile, when compared to the bottom one (p for trend <0.0005). The HR for CRP increased from 0.85 to 0.98 and 1.64 in the respective quartiles (p for trend 0.02). After further adjustment for covariates SUA still showed a clear statistically significant relationship with the outcome (p for trend 0.045), whereas CRP did not (p for trend 0.10). ConclusionThe data suggest that compared to inflammatory markers such as CRP and IL-6 serum uric acid levels may predict future CVD risk in patients with stable CHD with a risk increase even at levels considered normal. 相似文献
19.
Xanthine oxidase is a key enzyme that catalyses hypoxanthine and xanthine to uric acid and the overproduction of uric acid will lead to hyperuricemia which is an important cause of gout. In the present study, three chalcone derivatives were synthesized and evaluated for inhibitory activity against xanthine oxidase in vitro. Of the compounds, only Compound 1, 3,5,2′,4′-tetrahydroxychalcone, exhibited a significant inhibitory activity on xanthine oxidase with an IC 50 value of 22.5 μM. Lineweaver–Burk transformation of the inhibition kinetics data demonstrated that it was a competitive inhibitor of xanthine oxidase and Ki value was 17.4 μM. In vivo, intragastric administration of Compound 1 was able to significantly reduce serum uric acid levels and inhibited hepatic xanthine oxidase activities of hyperuricemic mice in a dose-dependent manner. Acute toxicity study in mice showed that Compound 1 was very safe at a dose of up to 5 g/kg. These results suggest that Compound 1 is a novel competitive xanthine oxidase inhibitor and is worthy of further development. 相似文献
20.
摘要 目的:分析血清抗凋亡多肽(HN)、补体C1q肿瘤坏死因子相关蛋白因子3(CTRP3)与冠心病(CHD)患者血脂及病情严重程度的关系。 方法:选取2017年1月至2018年12月期间西安医学院第二附属医院收治的CHD患者360例(CHD组),另选取同期健康体检者100例作为对照组(NC组),比较两组血清HN、CTRP3、血脂水平及基线资料;根据CHD患者病变支数分为单支病变组(n=131)、双支病变组(n=119)、多支病变组(n=110),根据冠状动脉造影结果测定Gensini积分,采用Pearson相关分析HN、CTRP3与血脂及Gensini积分的相关性。 结果:CHD组患者吸烟史比例、收缩压、空腹血糖、总胆固醇(TC)、甘油三酯(TG)及低密度脂蛋白(LDL-C)水平均高于NC组(P<0.05),血清HN、CTRP3和高密度脂蛋白(HDL-C)均低于NC组(P<0.05);CHD双支病变组和多支病变组患者吸烟史、空腹血糖、TC水平以及Gensini积分均高于单支病变组,CTRP3和HDL-C水平均低于单支病变组,多支病变组收缩压高于单支病变组,多支病变组吸烟史、空腹血糖和Gensini积分均高于双支病变组,且多支病变组CTRP3低于双支病变组(均P<0.05);Pearson相关分析结果显示:CHD患者血清HN水平与HDL-C水平呈正相关性,CHD患者血清CTRP3水平与Gensini积分呈负相关(P<0.05)。 结论:CHD患者血清中HN、CTRP3水平均显著降低,HN与HDL-C水平呈正相关,CTRP3降低程度与CHD患者病情严重程度有关,临床可考虑将其作为评估CHD患者病情严重程度的辅助血清学指标。 相似文献
|